The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-cyanophenyl 4-(phenyl(pyridin-3-yl)methyl)piperazine-1-carboxylate ID: ALA4519763
PubChem CID: 155542078
Max Phase: Preclinical
Molecular Formula: C24H22N4O2
Molecular Weight: 398.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1cccc(OC(=O)N2CCN(C(c3ccccc3)c3cccnc3)CC2)c1
Standard InChI: InChI=1S/C24H22N4O2/c25-17-19-6-4-10-22(16-19)30-24(29)28-14-12-27(13-15-28)23(20-7-2-1-3-8-20)21-9-5-11-26-18-21/h1-11,16,18,23H,12-15H2
Standard InChI Key: YFPDNRFKGHAKAQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
1.6902 -16.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6891 -16.8902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4039 -17.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1204 -16.8897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1176 -16.0591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4021 -15.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8355 -17.3011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5493 -16.8874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2589 -17.3022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9705 -16.8921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9735 -16.0666 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2586 -15.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5407 -16.0649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6889 -15.6558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4025 -16.0699 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6907 -14.8307 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1179 -15.6589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8301 -16.0767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5451 -15.6665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5473 -14.8406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8287 -14.4267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1168 -14.8393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2553 -16.0772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9687 -16.4917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8372 -18.1251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1217 -18.5381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1226 -19.3623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8383 -19.7745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5545 -19.3564 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5500 -18.5336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
11 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
23 24 3 0
19 23 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
7 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.47Molecular Weight (Monoisotopic): 398.1743AlogP: 3.86#Rotatable Bonds: 4Polar Surface Area: 69.46Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.25CX LogP: 3.69CX LogD: 3.66Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.67Np Likeness Score: -1.60
References 1. Alapafuja SO, Malamas MS, Shukla V, Zvonok A, Miller S, Daily L, Rajarshi G, Miyabe CY, Chandrashekhar H, Wood J, Tyukhtenko S, Straiker A, Makriyannis A.. (2019) Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment., 27 (1): [PMID:30446439 ] [10.1016/j.bmc.2018.11.003 ]